Holen Sie sich die Stockscreener-App
10.03
0.10%
0.010
Handel nachbörslich:
10.42
0.39
+3.89%
Eton Pharmaceuticals Inc Aktie (ETON) Neueste Nachrichten
Short Interest in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Drops By 6.2% - MarketBeat
HC Wainwright Has Bullish Forecast for ETON FY2024 Earnings - MarketBeat
Eton Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
HC Wainwright Has Bearish Estimate for ETON Q1 Earnings - MarketBeat
Investors Appear Satisfied With Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Prospects As Shares Rocket 29% - Simply Wall St
Eton Pharma Stock Soars Over 140% In 2024More Upside Ahead? - RTTNews
Eton Pharmaceuticals (NASDAQ:ETON) Earns Buy Rating from HC Wainwright - MarketBeat
Analyst Expectations For Eton Pharmaceuticals's Future - Benzinga
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q3 2024 Earnings Call Transcript - Insider Monkey
Eton Pharmaceuticals earnings beat by $0.03, revenue topped estimates - Investing.com UK
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results - The Manila Times
Eton Pharmaceuticals' (NASDAQ:ETON) growing losses don't faze investors as the stock spikes 16% this past week - Simply Wall St
Eton Pharmaceuticals (NASDAQ:ETON) Secures New U.S. Patent for Proprietary Formulation of Hydrocortisone - Defense World
Eton Pharmaceuticals stock hits 52-week high at $9.13 By Investing.com - Investing.com South Africa
Eton Pharmaceuticals stock hits 52-week high at $9.13 - Investing.com
What To Expect From Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings - Yahoo Finance
When the Price of (ETON) Talks, People Listen - Stock Traders Daily
Eton Pharmaceuticals (ETON) Set to Announce Earnings on Tuesday - MarketBeat
Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution) - The Manila Times
Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - The Manila Times
Eton Pharmaceuticals stock hits 52-week high at $8.79 amid growth - Investing.com India
Eton Pharmaceuticals stock hits 52-week high at $8.79 amid growth By Investing.com - Investing.com South Africa
Craig Hallum Increases Eton Pharmaceuticals (NASDAQ:ETON) Price Target to $15.00 - Defense World
Eton Pharmaceuticals price target raised to $15 from $10 at Craig-Hallum - Yahoo Finance
Eton Pharmaceuticals stock target raised, keeps buy on acquisition optimism By Investing.com - Investing.com Canada
Critical Insights From Eton Pharmaceuticals Analyst Ratings: What You Need To Know - Benzinga
Eton Pharmaceuticals (NASDAQ:ETON) Price Target Raised to $15.00 at Craig Hallum - MarketBeat
How To Trade (ETON) - Stock Traders Daily
Opaleye Management Inc. Reduces Stake in Eton Pharmaceuticals Inc. - GuruFocus.com
Short Interest in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Grows By 62.0% - MarketBeat
Eton Pharmaceuticals sees $79,814 stock purchase by Opaleye management - Investing.com South Africa
Eton Pharmaceuticals sees $79,814 stock purchase by Opaleye management By Investing.com - Investing.com Nigeria
Learn to Evaluate (ETON) using the Charts - Stock Traders Daily
Analysts Expect Breakeven For Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Before Long - Yahoo Finance
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Position Reduced by Squarepoint Ops LLC - Defense World
Eton Pharmaceuticals stock hits 52-week high at $7.66 By Investing.com - Investing.com South Africa
3 Stocks Insiders Are Buying Heavily in October 2024, and Why - The Tokenist
Eton Pharmaceuticals stock hits 52-week high at $7.66 - Investing.com
Adrenal Crisis Market to Rise by 2034 | Eton Pharmaceuticals, Antares Pharma, and others expected to boost market - openPR
Opaleye Management buys Eton Pharmaceuticals shares worth $434k - Investing.com India
Opaleye Management Inc. Bolsters Portfolio with Strategic Acquis - GuruFocus.com
Opaleye Management buys Eton Pharmaceuticals shares worth $434k By Investing.com - Investing.com Canada
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Major Shareholder Opaleye Management Inc. Purchases 11,248 Shares - MarketBeat
Is Eton Pharmaceuticals (NASDAQ:ETON) A Risky Investment? - Simply Wall St
Q4 2024 Earnings Forecast for Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Issued By HC Wainwright - MarketBeat
Eton Pharmaceuticals Inc [ETON] stock for 267,375 USD was bought by Opaleye Management Inc. - Knox Daily
Eton Pharmaceuticals stock target raised by H.C. Wainwright on Increlex acquisition - Investing.com Canada
0.79%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):